Atlas Trials

A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients

Clinical trial NCT01740271 · UNKNOWN

Trial details

NCT number
NCT01740271
Sponsor
AHS Cancer Control Alberta
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2012-12-01
Primary completion
2015-06-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.